Pharmacokinetics and Safety of Inhaled Ivermectin in Mice as a Potential COVID-19 Treatment

DOI record: { "DOI": "10.1016/j.ijpharm.2022.121688", "ISSN": [ "0378-5173" ], "URL": "http://dx.doi.org/10.1016/j.ijpharm.2022.121688", "alternative-id": [ "S0378517322002435" ], "article-number": "121688", "author": [ { "affiliation": [], "family": "Albariqi", "given": "Ahmed H.", "sequence": "first" }, { "affiliation": [], "family": "Wang", "given": "Yuncheng", "sequence": "additional" }, { "affiliation": [], "family": "Yoon Kyung Chang", "given": "Rachel", "sequence": "additional" }, { "affiliation": [], "family": "Quan", "given": "Diana H.", "sequence": "additional" }, { "affiliation": [], "family": "Wang", "given": "Xiaonan", "sequence": "additional" }, { "affiliation": [], "family": "Kalfas", "given": "Stefanie", "sequence": "additional" }, { "affiliation": [], "family": "Drago", "given": "John", "sequence": "additional" }, { "affiliation": [], "family": "Britton", "given": "Warwick J.", "sequence": "additional" }, { "affiliation": [], "family": "Chan", "given": "Hak-Kim", "sequence": "additional" } ], "container-title": [ "International Journal of Pharmaceutics" ], "content-domain": { "crossmark-restriction": false, "domain": [] }, "created": { "date-parts": [ [ 2022, 3, 19 ] ], "date-time": "2022-03-19T00:25:09Z", "timestamp": 1647649509000 }, "deposited": { "date-parts": [ [ 2022, 3, 19 ] ], "date-time": "2022-03-19T00:25:26Z", "timestamp": 1647649526000 }, "indexed": { "date-parts": [ [ 2022, 3, 19 ] ], "date-time": "2022-03-19T16:41:59Z", "timestamp": 1647708119160 }, "is-referenced-by-count": 0, "issn-type": [ { "type": "print", "value": "0378-5173" } ], "issued": { "date-parts": [ [ 2022, 3 ] ] }, "language": "en", "license": [ { "URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "content-version": "tdm", "delay-in-days": 0, "start": { "date-parts": [ [ 2022, 3, 1 ] ], "date-time": "2022-03-01T00:00:00Z", "timestamp": 1646092800000 } } ], "link": [ { "URL": "https://api.elsevier.com/content/article/PII:S0378517322002435?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://api.elsevier.com/content/article/PII:S0378517322002435?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining" } ], "member": "78", "original-title": [], "page": "121688", "prefix": "10.1016", "published": { "date-parts": [ [ 2022, 3 ] ] }, "published-print": { "date-parts": [ [ 2022, 3 ] ] }, "publisher": "Elsevier BV", "reference": [ { "article-title": "Preparation and Characterisation of inhalable ivermectin powders as a potential COVID-19 therapy", "author": "Albariqi", "first-page": "1", "journal-title": "J. Aerosol Med. Pulm. Drug Deliv.", "key": "10.1016/j.ijpharm.2022.121688_b0005", "volume": "35", "year": "2022" }, { "DOI": "10.1038/d41586-021-03672-3", "article-title": "Omicron likely to weaken COVID vaccine protection", "author": "Callaway", "doi-asserted-by": "crossref", "first-page": "367", "issue": "7889", "journal-title": "Nature", "key": "10.1016/j.ijpharm.2022.121688_b0010", "volume": "600", "year": "2021" }, { "DOI": "10.1016/j.antiviral.2020.104787", "article-title": "The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro", "author": "Caly", "doi-asserted-by": "crossref", "first-page": "104787", "journal-title": "Antiviral Res.", "key": "10.1016/j.ijpharm.2022.121688_b0015", "volume": "178", "year": "2020" }, { "DOI": "10.1038/s41598-020-74084-y", "article-title": "Nebulized ivermectin for COVID-19 and other respiratory diseases, a proof of concept, dose-ranging study in rats", "author": "Chaccour", "doi-asserted-by": "crossref", "first-page": "17073", "journal-title": "Sci. Rep.", "key": "10.1016/j.ijpharm.2022.121688_b0020", "volume": "10", "year": "2020" }, { "DOI": "10.1186/s12936-017-1801-4", "article-title": "Ivermectin to reduce malaria transmission I. Pharmacokinetic and pharmacodynamic considerations regarding efficacy and safety", "author": "Chaccour", "doi-asserted-by": "crossref", "first-page": "161", "journal-title": "Malar. J.", "key": "10.1016/j.ijpharm.2022.121688_b0025", "volume": "16", "year": "2017" }, { "DOI": "10.1016/j.jhep.2021.01.032", "article-title": "EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients", "author": "Cornberg", "doi-asserted-by": "crossref", "first-page": "944", "issue": "4", "journal-title": "J. Hepatol.", "key": "10.1016/j.ijpharm.2022.121688_b0030", "volume": "74", "year": "2021" }, { "DOI": "10.1101/2021.05.17.444467", "doi-asserted-by": "crossref", "key": "10.1016/j.ijpharm.2022.121688_b0035", "unstructured": "Dinesh Kumar, N., Ter Ellen, B.M., Bouma, E.M., Troost, B., van de Pol, D.P.I., van der Ende-Metselaar, H.H., van Gosliga, D., Apperloo, L., Carpaij, O.A., van den Berge, M., Nawijn, M.C., Stienstra, Y., Rodenhuis-Zybert, I.A., Smit, J.M., 2021. Moxidectin and Ivermectin Inhibit Sars-Cov-2 Replication in Vero E6 Cells but Not in Human Primary Airway Epithelium Cells. Antimicrob. Agents Chemother., AAC0154321." }, { "DOI": "10.1016/j.xphs.2021.01.017", "article-title": "Safety and Pharmacokinetic Assessments of a Novel Ivermectin Nasal Spray Formulation in a Pig Model", "author": "Errecalde", "doi-asserted-by": "crossref", "first-page": "2501", "issue": "6", "journal-title": "J. Pharm. Sci.", "key": "10.1016/j.ijpharm.2022.121688_b0040", "volume": "110", "year": "2021" }, { "DOI": "10.3390/pharmaceutics13030302", "article-title": "Drug Repurposing in the COVID-19 Era: Insights from Case Studies Showing Pharmaceutical Peculiarities", "author": "Gatti", "doi-asserted-by": "crossref", "first-page": "302", "issue": "3", "journal-title": "Pharmaceutics", "key": "10.1016/j.ijpharm.2022.121688_b0045", "volume": "13", "year": "2021" }, { "DOI": "10.1177/0018578718758972", "article-title": "A Case of Ivermectin-Induced Warfarin Toxicity: First Published Report", "author": "Gilbert", "doi-asserted-by": "crossref", "first-page": "393", "issue": "6", "journal-title": "Hosp. Pharm.", "key": "10.1016/j.ijpharm.2022.121688_b0050", "volume": "53", "year": "2018" }, { "DOI": "10.1177/009127002401382731", "article-title": "Safety, tolerability, and pharmacokinetics of escalating high doses of ivermectin in healthy adult subjects", "author": "Guzzo", "doi-asserted-by": "crossref", "first-page": "1122", "journal-title": "J. Clin. Pharmacol.", "key": "10.1016/j.ijpharm.2022.121688_b0055", "volume": "42", "year": "2002" }, { "author": "Hadj Hassine", "first-page": "e2313", "key": "10.1016/j.ijpharm.2022.121688_b0060", "series-title": "Covid-19 vaccines and variants of concern: A review", "year": "2021" }, { "key": "10.1016/j.ijpharm.2022.121688_b0065", "unstructured": "Johns Hopkins University, 2021. COVID-19 Map - Johns Hopkins Coronavirus Resource Center." }, { "DOI": "10.1016/j.vetpar.2004.11.028", "article-title": "Influence of the route of administration on efficacy and tissue distribution of ivermectin in goat", "author": "Lespine", "doi-asserted-by": "crossref", "first-page": "251", "issue": "3-4", "journal-title": "Vet. Parasitol.", "key": "10.1016/j.ijpharm.2022.121688_b0070", "volume": "128", "year": "2005" }, { "DOI": "10.1016/S0304-4017(99)00175-2", "article-title": "Comparative distribution of ivermectin and doramectin to parasite location tissues in cattle", "author": "Lifschitz", "doi-asserted-by": "crossref", "first-page": "327", "issue": "4", "journal-title": "Vet. Parasitol.", "key": "10.1016/j.ijpharm.2022.121688_b0075", "volume": "87", "year": "2000" }, { "DOI": "10.1016/j.antiviral.2013.10.004", "article-title": "Nuclear import and export inhibitors alter capsid protein distribution in mammalian cells and reduce Venezuelan Equine Encephalitis Virus replication", "author": "Lundberg", "doi-asserted-by": "crossref", "first-page": "662", "issue": "3", "journal-title": "Antiviral Res.", "key": "10.1016/j.ijpharm.2022.121688_b0080", "volume": "100", "year": "2013" }, { "DOI": "10.1016/j.antiviral.2018.09.010", "article-title": "Ivermectin inhibits DNA polymerase UL42 of pseudorabies virus entrance into the nucleus and proliferation of the virus in vitro and vivo", "author": "Lv", "doi-asserted-by": "crossref", "first-page": "55", "journal-title": "Antiviral Res.", "key": "10.1016/j.ijpharm.2022.121688_b0085", "volume": "159", "year": "2018" }, { "DOI": "10.1016/j.intimp.2021.108004", "article-title": "Safety of inhaled ivermectin as a repurposed direct drug for treatment of COVID-19: A preclinical tolerance study", "author": "Mansour", "doi-asserted-by": "crossref", "journal-title": "Int. Immunopharmacol.", "key": "10.1016/j.ijpharm.2022.121688_b0090", "volume": "99", "year": "2021" }, { "DOI": "10.1093/jac/dks147", "article-title": "Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug", "author": "Mastrangelo", "doi-asserted-by": "crossref", "first-page": "1884", "issue": "8", "journal-title": "J. Antimicrob. Chemother.", "key": "10.1016/j.ijpharm.2022.121688_b0095", "volume": "67", "year": "2012" }, { "key": "10.1016/j.ijpharm.2022.121688_b0100", "unstructured": "Merck Sharp & Dohme BV Stromectol (Ivermectin): Product Information. Merck 2018 Sharp & Dohme Corp., Netherlands" }, { "DOI": "10.1016/S2214-109X(19)30453-X", "article-title": "Safety of oral ivermectin during pregnancy: a systematic review and meta-analysis", "author": "Nicolas", "doi-asserted-by": "crossref", "first-page": "e92", "issue": "1", "journal-title": "Lancet Glob Health", "key": "10.1016/j.ijpharm.2022.121688_b0105", "volume": "8", "year": "2020" }, { "DOI": "10.1016/j.ijantimicag.2007.08.023", "article-title": "Ivermectin: 25 years and still going strong", "author": "Õmura", "doi-asserted-by": "crossref", "first-page": "91", "issue": "2", "journal-title": "Int J Antimicrob Agents", "key": "10.1016/j.ijpharm.2022.121688_b0110", "volume": "31", "year": "2008" }, { "DOI": "10.1016/j.pt.2014.07.005", "article-title": "Ivermectin: panacea for resource-poor communities?", "author": "Ōmura", "doi-asserted-by": "crossref", "first-page": "445", "issue": "9", "journal-title": "Trends Parasitol", "key": "10.1016/j.ijpharm.2022.121688_b0115", "volume": "30", "year": "2014" }, { "DOI": "10.1016/j.pharmthera.2017.04.003", "article-title": "Inhaled efficacious dose translation from rodent to human: A retrospective analysis of clinical standards for respiratory diseases", "author": "Phillips", "doi-asserted-by": "crossref", "first-page": "141", "journal-title": "Pharmacol. Ther.", "key": "10.1016/j.ijpharm.2022.121688_b0120", "volume": "178", "year": "2017" }, { "DOI": "10.1016/j.ijpharm.2010.03.017", "article-title": "Formulation strategy and use of excipients in pulmonary drug delivery", "author": "Pilcer", "doi-asserted-by": "crossref", "first-page": "1", "issue": "1-2", "journal-title": "Int. J. Pharm.", "key": "10.1016/j.ijpharm.2022.121688_b0125", "volume": "392", "year": "2010" }, { "DOI": "10.3791/61469", "article-title": "Intratracheal Administration of Dry Powder Formulation in Mice", "author": "Qiu", "doi-asserted-by": "crossref", "journal-title": "J Vis Exp.", "key": "10.1016/j.ijpharm.2022.121688_b0130", "year": "2020" }, { "DOI": "10.1101/2020.12.28.20248950", "doi-asserted-by": "crossref", "key": "10.1016/j.ijpharm.2022.121688_b0135", "unstructured": "M. Sallam COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates 2021 Vaccines (Basel) 9" }, { "DOI": "10.1159/000056764", "article-title": "Lung lining liquid - the hidden depths. The 5th Nils W. Svenningsen memorial lecture", "author": "Walters", "doi-asserted-by": "crossref", "first-page": "2", "journal-title": "Biol. Neonate", "key": "10.1016/j.ijpharm.2022.121688_b0140", "volume": "81 Suppl 1", "year": "2002" }, { "key": "10.1016/j.ijpharm.2022.121688_b0145", "unstructured": "World Health Organization, 2021. Tracking SARS-CoV-2 variants." }, { "DOI": "10.1016/S0140-6736(21)00306-8", "article-title": "Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment", "author": "Wouters", "doi-asserted-by": "crossref", "first-page": "1023", "issue": "10278", "journal-title": "Lancet", "key": "10.1016/j.ijpharm.2022.121688_b0150", "volume": "397", "year": "2021" }, { "DOI": "10.1016/j.cmpb.2010.01.007", "article-title": "PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel", "author": "Zhang", "doi-asserted-by": "crossref", "first-page": "306", "issue": "3", "journal-title": "Comput. Methods Programs Biomed.", "key": "10.1016/j.ijpharm.2022.121688_b0155", "volume": "99", "year": "2010" } ], "reference-count": 31, "references-count": 31, "relation": {}, "resource": { "primary": { "URL": "https://linkinghub.elsevier.com/retrieve/pii/S0378517322002435" } }, "score": 1, "short-container-title": [ "International Journal of Pharmaceutics" ], "short-title": [], "source": "Crossref", "subject": [ "Pharmaceutical Science" ], "subtitle": [], "title": [ "Pharmacokinetics and Safety of Inhaled Ivermectin in Mice as a Potential COVID-19 Treatment" ], "type": "journal-article" }